SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
3.770
-0.120 (-3.08%)
At close: Jan 30, 2026, 4:00 PM EST
3.720
-0.050 (-1.33%)
Pre-market: Feb 2, 2026, 8:52 AM EST
SLS Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$7.00
Upside
+85.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +85.68% | Jul 16, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -20.42% | Nov 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -20.42% | Sep 7, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +112.20% | Nov 15, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +59.15% | Jun 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $18 | Buy | Initiates | $18 | +377.45% | Jul 21, 2021 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +218.30% | Nov 15, 2019 |
| Oppenheimer | Oppenheimer | Buy Initiates $650 | Buy | Initiates | $650 | +17,141.38% | Nov 1, 2018 |
| Maxim Group | Maxim Group | Strong Buy Maintains $650 → $250 | Strong Buy | Maintains | $650 → $250 | +6,531.30% | Jul 20, 2018 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 19, 2018 |